Crescent Capital BDC Inc

Crescent Capital BDC Inc(CCAP)股票分析

$9.640

+0.299 (+3.10%)收盤時

Loading chart…
最高
9.720
開盤
9.500
成交量加權均價
9.62
成交量
174.07K
市值
702.69M
最低
9.485
成交金額
1.67M
企業價值/稅息折舊攤銷前利潤(TTM)
9.72

Crescent Capital BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It invests primarily in secured debt, including first lien, unitranche first lien and second-lien debt, and unsecured debt, including mezzanine and subordinated debt, as well as related equity securities of private United States middle-market companies. It is focused on purchasing interests in loans or making debt investments, either directly from its target companies as primary market or private credit investments (private credit transactions), or primary or secondary market bank loans or high-yield transactions in the syndicated market (syndicated loans and bonds). Although its focus is on investing in less liquid private credit transactions. The Company is managed by Crescent Cap Advisors, LLC.

AI 分析 of Crescent Capital BDC Inc (CCAP)

持有

Crescent Capital BDC Inc (CCAP) is currently priced at $9.415, which is significantly below its 52-week high of $15.18, suggesting potential upside. However, the stock has a high RSI of 75.951, indicating it may be overbought. Additionally, the forward P/E ratio is 6.7159, which is attractive, but the company recently reported a decline in net income and cut its dividend by 19%, raising concerns about its financial health. The main risk is the EPS forecast of $0.35 for the next quarter, which is lower than the previous quarter's reported EPS of $0.36, indicating ongoing challenges. Therefore, while there is potential for recovery, the current indicators suggest a cautious approach rather than a strong buy.

估值指標

Crescent Capital BDC Inc(CCAP)目前預期本益比為 6.72,5 年平均預期本益比為 8.88。

預期本益比

合理
5 年均值 P/E
8.88
目前P/E
6.72
高估
14.27
低估
3.50

預期 EV/EBITDA

高估
5 年均值 EV/EBITDA
1.97
目前EV/EBITDA
9.72
高估
6.43
低估
-2.49

預期股價營收比

低估
5 年均值 P/S
3.40
目前P/S
2.41
高估
4.09
低估
2.71

Alphio AI 對 CCAP 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CCAP

$16.82

情境價格

基

基準

基準 · 50%CCAP

$16.07

情境價格

悲

悲觀

悲觀 · 25%CCAP

$14.23

情境價格

持有 CCAP 的大戶

C

Cerberus Capital Management, L.P.

+ 持有CCAP

+6.90%

3個月報酬率

B

Blackstone Inc.

+ 持有CCAP

-8.84%

3個月報酬率

F

Fidelity National Financial, Inc.

+ 持有CCAP

-14.26%

3個月報酬率

CCAP 常見問題 —— 由 Alphio AI 解答

Crescent Capital BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It invests primarily in secured debt, including first lien, unitranche first lien and second-lien debt, and unsecured debt, including mezzanine and subordinated debt, as well as related equity securities of private United States middle-market companies. It is focused on purchasing interests in loans or making debt investments, either directly from its target companies as primary market or private credit investments (private credit transactions), or primary or secondary market bank loans or high-yield transactions in the syndicated market (syndicated loans and bonds). Although its focus is on investing in less liquid private credit transactions. The Company is managed by Crescent Cap Advisors, LLC. It operates in the Financials sector.

Crescent Capital BDC Inc (CCAP) is currently priced at $9.415, which is significantly below its 52-week high of $15.18, suggesting potential upside. However, the stock has a high RSI of 75.951, indicating it may be overbought. Additionally, the forward P/E ratio is 6.7159, which is attractive, but the company recently reported a decline in net income and cut its dividend by 19%, raising concerns about its financial health. The main risk is the EPS forecast of $0.35 for the next quarter, which is lower than the previous quarter's reported EPS of $0.36, indicating ongoing challenges. Therefore, while there is potential for recovery, the current indicators suggest a cautious approach rather than a strong buy.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易